-
Director Appointment
Ramu Lavanya was appointed as a Additional Director was appointed as a Additional Director on 02 Jan 2025 & has been associated with this company since 1 year 21 days . was recorded as a recent event.
-
Annual General Meeting
The activity Sundar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
-
Balance Sheet
Sundar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
-
Director Appointment
The activity Ramu Krishnan was appointed as a Director was appointed as a Director on 08 Apr 2005 & has been associated with this company since 20 years 9 months . was completed.
-
Company Incorporation
The activity Sundar Pharmaceuticals Private Limited was registered on 08 Apr 2005 with Roc Chennai & aged 20 years 9 months as per MCA records. was completed.
Sundar Pharmaceuticals Private Limited - Company Profile
Sundar Pharmaceuticals Private Limited, a active private limited company, was established on 08 April 2005 in Chennai 600 018, Tamil Nadu, India. Engaging in animal feeds within the agriculture sector, it holds CIN: U24239TN2005PTC055911. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹6.10 M.
It upholds a compliant status. Its leadership includes Ramu Krishnan (Director), Ramu Lavanya (Additional Director). Past directors included Ramu Sundaravalli, Krishnamachari Ramu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6G, Century Plaza560-562 Anna Salai Teynampet, Chennai 600 018, Tamil Nadu.
Company Details
- CIN/LLPIN
U24239TN2005PTC055911
- Registration Number
055911
- Incorporation Date
08 April 2005
- Authorized Capital
₹1.00 Cr
- Paid-Up Capital
₹6.10 M
- ROC Code
Roc Chennai
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 6.10 M
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 25.00%
- Profit Growth 11.79%
- Ebitda 13.99%
- Net Worth -7.36%
- Total Assets -4.66%
Sundar Pharmaceuticals Private Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Sundar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramu Krishnan | Director | 08 Apr 2005 | Current |
| Ramu Lavanya | Additional Director | 02 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jan 2025 | Past |
| Pramod Abcsdd | Director | 22 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sundar Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 25% increase. The company also saw a substantial improvement in profitability, with a 11.79% increase in profit. The company's net worth dipped by a decrease of 7.36%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2017, Sundar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Sundar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Sundar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Sundar Pharmaceuticals Private Limited?
The CIN of Sundar Pharmaceuticals Private Limited is U24239TN2005PTC055911.
Where is Sundar Pharmaceuticals Private Limited headquartered?
Sundar Pharmaceuticals Private Limited is headquartered at 6G, Century Plaza560-562 Anna Salai Teynampet, Chennai 600 018, Tamil Nadu.
When was Sundar Pharmaceuticals Private Limited incorporated?
Sundar Pharmaceuticals Private Limited was incorporated on 08 April 2005.
Who are the current directors of Sundar Pharmaceuticals Private Limited?
The current directors of Sundar Pharmaceuticals Private Limited are
What is the primary industry of Sundar Pharmaceuticals Private Limited?
The primary industry of Sundar Pharmaceuticals Private Limited is Agriculture.
Is Sundar Pharmaceuticals Private Limited a listed company?
Sundar Pharmaceuticals Private Limited is unlisted.
What is the capital structure of Sundar Pharmaceuticals Private Limited?
The authorized capital of Sundar Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹6.10 M.
What is the compliance status of Sundar Pharmaceuticals Private Limited?
The compliance status of Sundar Pharmaceuticals Private Limited is Compliant.
+91-XXXXXXXXXX